Sarepta Therapeutics (SRPT ) PT Lowered to $90 at Morgan Stanley
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $17.50 -0.4%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on Sarepta Therapeutics (NASDAQ: SRPT ) to $90.00 (from $93.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Sarepta Therapeutics (SRPT) PT Lowered to $20 at JPMorgan
- TMBThanachart Bank PCL (TTB:TB) PT Raised to THB3.30 at Macquarie
- Sarepta's Elevidys shows benefit in older Duchenne patients
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
